American Bio Medica's latest marketcap:
As of 06/17/2025, American Bio Medica's market capitalization has reached $48. According to our data, American Bio Medica is the 49357th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 48 |
| Revenue (ttm) | 726,000 |
| Net Income (ttm) | 850,000 |
| Shares Out | 48.1 M |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
American Bio Medica's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/17/2025 | $48 | 9920.83% | 49357 |
| 12/30/2024 | $48 | 0% | 48419 |
| 12/29/2023 | $48 | -99.98% | 46744 |
| 12/30/2022 | $264,542 | -85.18% | 45002 |
| 12/31/2021 | $1.78 M | -63.58% | 42967 |
| 12/31/2020 | $4.9 M | 114.26% | 39730 |
| 12/31/2019 | $2.29 M | 9.89% | 37017 |
| 12/31/2018 | $2.08 M | -28.95% | 35617 |
| 12/29/2017 | $2.93 M | -1.95% | 34084 |
| 12/30/2016 | $2.99 M | -12.38% | 32049 |
Company Profile
About American Bio Medica Corporation
American Bio Medica Corporation specializes in the manufacture and sale of lateral flow immunoassay tests, primarily designed for the immediate detection of drugs in urine and oral fluids.
Key Products
- Rapid Drug Screen: Detects 2 to 10 drugs in urine.
- RDS InCup: A drug-testing cup detecting 1 to 12 drugs.
- Rapid TOX: A cassette-based test detecting 1 to 10 drugs.
- Rapid TOX Cup II: A drug-testing cup detecting 1 to 16 drugs.
- OralStat: Detects drugs in oral fluids, available in private-labeled versions.
- Respiratory Syncytial Virus Test: For infectious disease detection.
Additional Offerings
The company also provides:
- Distribution of products for substance abuse and infectious disease detection.
- Strip contract manufacturing, assembly, and packaging services for diagnostic companies.
Markets Served
American Bio Medica serves:
- Rehabilitation/drug treatment
- Pain management
- Clinical, government, and employment/workplace markets
Global Presence
The company operates in:
- United States
- North America
- Europe
- Asia Pacific
- South America
Company Background
Originally named American Micro Media, Inc., the company rebranded as American Bio Medica Corporation in September 1992. Founded in 1986, it is headquartered in Kinderhook, New York.
Frequently Asked Questions
-
What is American Bio Medica's (OTC-ABMC) current market cap?As of 06/17/2025, American Bio Medica (including the parent company, if applicable) has an estimated market capitalization of $48 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does American Bio Medica (OTC-ABMC) rank globally by market cap?American Bio Medica global market capitalization ranking is approximately 49357 as of 06/17/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.